2018
DOI: 10.2174/0929867324666171009121702
|View full text |Cite
|
Sign up to set email alerts
|

Gut Microbiota as a Therapeutic Target for Metabolic Disorders

Abstract: A growing body of evidence highlights the role of gut microbiota in the development of dysbiosis, which in turn influences host metabolism and disease phenotypes. Further studies are required to elucidate the precise mechanisms by which gut microbiota-derived mediators induce metabolic disorders and modulating interventions exert their beneficial effects in humans. The gut microbiota represents a novel potential therapeutic target for a range of metabolic disorders.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
48
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 0 publications
0
48
0
1
Order By: Relevance
“…Recently, gut microbiota has been regarded as an essential organ, playing critical roles in controlling host metabolic homeostasis and organ physiology. In addition, gut microbiota alterations have been suggested to contribute to the pathogenesis of insulin resistance 7,8 . Gut microbiota vary with race, diet and lifestyle [9][10][11] .…”
Section: Introductionmentioning
confidence: 99%
“…Recently, gut microbiota has been regarded as an essential organ, playing critical roles in controlling host metabolic homeostasis and organ physiology. In addition, gut microbiota alterations have been suggested to contribute to the pathogenesis of insulin resistance 7,8 . Gut microbiota vary with race, diet and lifestyle [9][10][11] .…”
Section: Introductionmentioning
confidence: 99%
“…На даний час мікробіоту визнано справжнім функціональним «органом» через її величезний вплив на здоров'я людини. Переважна більшість мікроорганізмів перебуває в кишковому тракті, де вони беруть активну участь у травленні, харчуванні, імунній регуляції та обміні речовин [12][13][14]. Склад та активність мікробіоти кишечнику можуть змінюватися з часом і залежать від різних чинників, включаючи спадковість, стать, вік, особливості харчування, стан здоров'я та застосування лікарських засобів і зокрема антибіотиків [15].…”
Section: зв'язок кишкової мікробіоти з дисметаболічними захворюваннямunclassified
“…The possible relationship(s) between intestinal dysbiosis and various degenerative intestinal‐based diseases, e.g. diabetes and obesity, is an ongoing focus of intense investigation . As a consequence of the results of such research, the focus is now on therapeutic strategies for such diseases based on modification of the gut microbiota .…”
Section: Molecular Fingerprint Potentially Produced By Gut Microbiotamentioning
confidence: 99%
“…Kang and co‐workers also reported different strategies involving fecal gut microbiota transplantation to treat obesity. Other studies correlated other degenerative diseases to gut microbiota activities and suggested therapeutic strategies to alleviate those disease states …”
Section: Molecular Fingerprint Potentially Produced By Gut Microbiotamentioning
confidence: 99%